Using a combination of approaches, researchers characterized influenza A viruses at two live animal swine markets in Minnesota.
Researchers saw high recurrence risk in oropharyngeal carcinoma patients with human papillomavirus type 16 DNA in their spit samples both before and after treatment.
Roche's Cobas EGFR v2 mutation test will be able to identify advanced NSCLC patients with EGFR mutations who are likely to benefit from the next-generation treatment.
Qiagen posted revenues of $319.5 million compared to $330.8 million in the year-ago period, and beat analysts' consensus estimate on the top and bottom lines.
The firm increased its MDx revenues 7 percent from a year ago and beat the consensus Wall Street estimates on the top and bottom lines.
In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.
A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.
Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.
Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."